Stage 0 Gastric Cancer
Current Clinical Trials
Standard treatment options:
Stage 0 is gastric cancer confined to mucosa. Experience in Japan, where stage
0 is diagnosed frequently, indicates that more than 90% of patients treated
by gastrectomy with lymphadenectomy will survive beyond 5 years. An American
series has confirmed these results.[1]
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage 0 gastric cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References
-
Green PH, O'Toole KM, Slonim D, et al.: Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center. Am J Med 85 (5): 658-61, 1988.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |